Immuno Concepts N.A. Ltd. Company Profile
Immuno Concepts was founded in 1979 with a commitment to advance the quality of diagnostic assays for systemic rheumatic diseases. Over twenty years later we still honor that commitment. Our company motto, "Quality People Setting the Quality Standard," further reflects this commitment. We are proud to display that we have a quality system that is certified to ISO 9001 and we are actively pursuing CE mark certification for our products. In 1979 Immuno Concepts pioneered the conversion from rodent tissue to HEp-2 cells for detection of anti-nuclear antibodies (ANAs). Using genetic engineering we developed HEp-2000, an ANA substrate with increased sensitivity for detection of autoantibodies to SS-A/Ro. The advantages of the HEp-2000 substrate over conventional HEp-2 have been documented in several published papers from well-known institutions and are discussed later in this catalog. Immuno Concepts was the first company to offer a non-fluorescent ANA. Our Colorzyme methodology uses a patented stabilized color reagent system that allows slide-based assays to be read using common bright field microscopy. The Colorzyme format is available for ANA, nDNA and EBV assays
Location
9779 D Business Park Drive
Sacramento
California
95827
United States of America
Contact
Phone: 916-363-2649
News Articles
Bristol-Myers Squibb forms International Immuno-Oncology Network
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientifi...
BMS joins with cancer research institutions to advance science of immuno-oncology
Bristol-Myers Squibb (BMS) has formed the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to advance the scientific understanding of immun...
BMS announces global collaboration for immuno-oncology
Global biopharmaceutical company Bristol-Myers Squibb has announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims t...
BMS forms international industry-academe immuno-oncology consortium
Bristol-Myers Squibb has completed the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understa...
BMS launches global collaboration with academia to advance immuno-oncology
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientifi...
Bristol-Myers Squibb announces formation of International Immuno-Oncology Network (II-ON)
Bristol-Myers Squibb announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understandin...
Galapagos reaches milestone in immuno-inflammation alliance with GSK
Galapagos has reached a milestone in its immuno-inflammation alliance with GlaxoSmithKline (GSK) by delivering a fifth pre-clinical drug candidate.
BMS forms immuno-oncology collaboration with 10 US and EU cancer institutes
Bristol-Myers Squibb (BMS) formed the International Immuno-Oncology Network (II-ON) with 10 research centers in the US and EU as a global collaboration between industry and academia to broaden global...
Drugs and Medications
Enriched foam hand sanitizer [Rubbermaid Commercial Products LLC]
TC ENRICHED FOAM Hand Sanitizer
Moisturizing instant hand sanitizer [Rubbermaid Commercial Products LLC]
TC Moisturizing Instant Hand Sanitizer
Enriched foam alcochol-free hand sanitizer [Rubbermaid Commercial Products LLC]
TC ENRICHED FOAM Alcohol-Free Instant Hand Sanitizer
Enriched foam antibacterial soap [Rubbermaid Commercial Products LLC]
TC ENRICHED FOAM Antibacterial Soap
Freshands [Spa Concepts, Inc.]
FresHands 6576 Drug Facts and Label
PubMed Articles
Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody Therapy.
Summation Monoclonal antibodies (mAbs) have been approved for therapeutic use in a broad range of medical indications, especially in oncology, and are forming the most rapidly expanding category of ph...
BACKGROUND: Immuno-cell therapy using activated lymphocytes (ALs) and/or dendritic cells (DCs) is considered one of the less toxic supportive therapies compared with conventional chemotherapy and radi...
Evaluation of the Content Coverage of SNOMED CT Representing ICNP Seven-axis Version 1 Concepts.
Objectives: The purpose of this study is to evaluate the ability of SNOMED CT (Systematized Nomenclature of Medicine Clinical Terms) to represent the concepts of the ICNP version 1 - the seven-axis m...
Due to the specific habitat conditions in which they live, earthworms are constantly exposed to pathogens. Consequently, they have evolved various immuno-defense mechanisms, including cellular (coelom...
An ICF-CY-based content analysis of the Vineland Adaptive Behavior Scales-II.
Background The International Classification of Functioning, Disability and Health (ICF), and its version for children and youth (ICF-CY), has been increasingly adopted as a system to describe function...
Clinical Trials
Exposure Chamber Trial With Cat Immunotherapy
The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.
We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy. Therefore, we challenged 12 patients for 14 we...
Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
The purpose of this study is to determine the safety of making and giving Epstein-Barr virus (EBV) immunotherapy products to subjects with nasopharyngeal carcinoma (NPC) associated with EB...
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
The purpose of this study is to determine if small oral and sublingual doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.
Multi-center, prospective randomised phase III study evaluating capecitabine in combination with standard-immunotherapy versus standard-immunotherapy alone as first-line therapy in patient...
Companies
Immuno Concepts was founded in 1979 with a commitment to advance the quality of diagnostic assays for systemic rheumatic diseases. Over twenty years later we still honor that commitment. Our company m...
AV Concepts is the inspired place where creative and technology meets. For 24 years AV Concepts has not only been a full-service supplier of video, audio, lighting and technical s...
Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases...
Simulated Environment Concepts, Inc.
Simulated Environment Concepts, Inc. (SE Concepts) (SYMBOL: SMEV) is an industry leading manufacturer and developer of cutting edge medical, health and wellness equipment.
Simulated Environment Concepts
Simulated Environment Concepts, Inc. (SE Concepts) (SYMBOL: SMEV) is an industry leading manufacturer and developer of cutting edge medical, health and wellness equipment.
More Information about "Immuno Concepts N.A. Ltd." on BioPortfolio
We have published hundreds of Immuno Concepts N.A. Ltd. news stories on BioPortfolio along with dozens of Immuno Concepts N.A. Ltd. Clinical Trials and PubMed Articles about Immuno Concepts N.A. Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno Concepts N.A. Ltd. Companies in our database. You can also find out about relevant Immuno Concepts N.A. Ltd. Drugs and Medications on this site too.
